TLR4 and carcinoma: Growing evidence supports TLR4’s crucial role in the so-called liver inflammation–fibrosis–carcinoma (IFC) sequence, modulating the inflammatory response in viral hepatitis, autoimmune liver disease, and alcohol-induced liver damage.